Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology

George M. Rodgers, David Cella, Asher Chanan-Khan, Carolyn Chesney, Charles Cleeland, Peter F. Coccia, George D. Demetri, Benjamin Djulbegovic, Jennifer L. Garst, Margaret Gore, Eric H. Kraut, Weei Chin Lin, Michael Millenson, Victoria Mock, Denise Reinke, Joseph Rosenthal, Paul Sabbatini

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy.

Original languageEnglish (US)
Pages (from-to)772-789
Number of pages18
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number6
StatePublished - Nov 1 2005

    Fingerprint

Keywords

  • Anemia
  • Chemotherapy
  • Darbapoetin
  • Epoetin
  • Erythropoietin
  • Ferric gluconate
  • Heme iron polypeptide
  • Hemoglobin
  • Iron dextran
  • Iron sucrose
  • NCCN Clinical Practice Guidelines in Oncology
  • Quality of life
  • Serum ferritin

ASJC Scopus subject areas

  • Oncology

Cite this

Rodgers, G. M., Cella, D., Chanan-Khan, A., Chesney, C., Cleeland, C., Coccia, P. F., Demetri, G. D., Djulbegovic, B., Garst, J. L., Gore, M., Kraut, E. H., Lin, W. C., Millenson, M., Mock, V., Reinke, D., Rosenthal, J., & Sabbatini, P. (2005). Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 3(6), 772-789.